<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - POZN</title>
<description>International Business News - POZN</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>FDA requests additional study on Pozen drug</title>
  <description>Drug developer Pozen Inc. said Friday federal regulators have requested an additional study of its experimental heart treatment before considering it for approval.</description>
    <link>http://www.ibtimes.com/articles/20080801/fda-requests-additional-study-on-pozen-drug.htm</link> 
  <pubDate>Fri, 01 Aug 2008 16:49:40 EDT</pubDate>
  </item>


  <item>
  <title>Pozen says drug candidate shows bioequivalence</title>
  <description>Drug developer Pozen Inc. said Monday that a cardiovascular disease drug candidate demonstrated bioequivalence to enteric-coated aspirin, possibly paving the way for regulatory approval.</description>
    <link>http://www.ibtimes.com/articles/20080609/pozen-says-drug-candidate-shows-bioequivalence.htm</link> 
  <pubDate>Mon, 09 Jun 2008 13:49:26 EDT</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Mirant, Pozen</title>
  <description>Among the earnings stories for Thursday, May 8, from AP Financial News: ATLANTA (AP) _ Mirant Corp. said Thursday its first-quarter loss widened on increased fuel costs and lower volumes in the power generator&amp;#39;s Northeast region.</description>
    <link>http://www.ibtimes.com/articles/20080508/earnings-roundup-mirant-pozen.htm</link> 
  <pubDate>Thu, 08 May 2008 15:22:03 EDT</pubDate>
  </item>


  <item>
  <title>Pozen projects full-year revenue above Wall Street estimates</title>
  <description>Drug developer Pozen Inc. on Thursday raised its outlook for 2008 revenue to between $62 million and $68 million, well above Wall Street estimates. Analysts polled by Thomson Financial expect 2008 revenue of $52.2 million.</description>
    <link>http://www.ibtimes.com/articles/20080508/pozen-projects-full-year-revenue-above-wall-street-estimates.htm</link> 
  <pubDate>Thu, 08 May 2008 10:41:06 EDT</pubDate>
  </item>


  <item>
  <title>Pozen 1Q loss more than triples on higher operating expenses</title>
  <description>Drug developer Pozen Inc. said Thursday that its first-quarter loss more than tripled on higher operating expenses, though the loss was in-line with Wall Street estimates.</description>
    <link>http://www.ibtimes.com/articles/20080508/pozen-1q-loss-more-than-triples-on-higher-operating-expenses.htm</link> 
  <pubDate>Thu, 08 May 2008 10:25:26 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: Analyst questions Pozen drug sales</title>
  <description>A Cowen analyst expects limited success for Pozen and GlaxoSmithKline&amp;#39;s migraine drug Treximet due to generic competition and reimbursement questions.</description>
    <link>http://www.ibtimes.com/articles/20080421/ahead-of-the-bell-analyst-questions-pozen-drug-sales.htm</link> 
  <pubDate>Mon, 21 Apr 2008 08:21:50 EDT</pubDate>
  </item>


  <item>
  <title>Intel, Wells Fargo, Coke among big market movers Wednesday</title>
  <description>
Continental Airlines Inc. said Thursday that soaring fuel costs pushed it to a loss for the first quarter, and it plans to retrench by mothballing planes and reducing flights.

Houston-based Continen...</description>
    <link>http://www.ibtimes.com/articles/20080416/intel-wells-fargo-coke-among-big-market-movers-wednesday.htm</link> 
  <pubDate>Wed, 16 Apr 2008 12:37:27 EDT</pubDate>
  </item>


  <item>
  <title>Premarket Movers: Intel, Dow stocks lead gainers</title>
  <description>
A trio of Dow components gave investors hope in a flagging economy, reporting robust first-quarter results before the bell Wednesday that topped Wall Street projections and spurred premarket trading....</description>
    <link>http://www.ibtimes.com/articles/20080416/premarket-movers-intel-dow-stocks-lead-gainers.htm</link> 
  <pubDate>Wed, 16 Apr 2008 09:09:34 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: Migraine Drug</title>
  <description>
Drug makers GlaxoSmithKline PLC and Pozen Inc. are expected to hear Tuesday whether federal regulators will approve their long-delayed migraine drug.

Treximet is a combination of an anti-inflammator...</description>
    <link>http://www.ibtimes.com/articles/20080415/ahead-of-the-bell-migraine-drug.htm</link> 
  <pubDate>Tue, 15 Apr 2008 06:22:10 EDT</pubDate>
  </item>


  <item>
  <title>Pozen Shares Sink on FDA Warning Letter</title>
  <description>
Shares of Pozen Inc. fell Tuesday on speculation that a federal warning letter issued to GlaxoSmithKline PLC could delay approval of a drug the companies are developing.

Pozen and British drug maker...</description>
    <link>http://www.ibtimes.com/articles/20080408/pozen-shares-sink-on-fda-warning-letter.htm</link> 
  <pubDate>Tue, 08 Apr 2008 15:20:33 EDT</pubDate>
  </item>


</channel>
</rss>